Johnson & Johnson targets 100 million doses of vaccine by spring. The stock market is counting on that.
California health official calls for 300,000 vaccinations to be suspended Modern after reports of allergic reactions
The Johnson & Johnson Covid-19 vaccine could change the course of the pandemic. Investors will soon know if it works.
The third vaccine could be authorized in the UK within weeks, increasing the momentum of mass immunization, said the scientist
